Germline PGX molecular testing

Active Awarded Last action

Contract number
36C10X24D0028
Awardee
Awarding agency
Task orders
3 $9,529,174 obligated

Award facts

Opportunity
Combined order value
$16,096,200 Current and potential, with all options
Last date to order 41% complete
IDV ceiling 10% used
$99,032,828.20
Award type
Multiple award
Who can order
Only the awarding agency
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
Full and Open Competition · 10 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs Strategic Acquisition Center Frederick awarded a multiple-award indefinite delivery contract to Fulgent Therapeutics LLC on September 30, 2024, with a ceiling of $99,032,828.20 for germline pharmacogenomic and genetic testing services.

Performance extends through September 29, 2029. The contract covers national access to germline genetic testing across oncology, medical genetics, and pharmacogenomics programs for patients eligible to receive care throughout the VA enterprise. Work is performed in Frederick, Maryland. The originating solicitation required offerors to provide all personnel, equipment, supplies, and services necessary to perform testing according to a Performance Work Statement while maintaining compliance with relevant regulations and accreditations. Offerors demonstrated capacity to service all VA Oncology, Medical Genetics, and Pharmacogenomics practice sites, including growth as additional sites are added. NAICS code 621511 (Medical Laboratories); PSC Q301.

Three delivery orders have been issued under this IDIQ. A supplemental agreement for germline PGX molecular testing, awarded September 30, 2024, carries a $2,949,000 ceiling. A Year 2 within-scope modification supporting the Veterans Health Administration National Oncology Program, awarded September 30, 2025, carries a $6,573,600 ceiling with completion through September 29, 2029. A germline PGX molecular testing delivery order awarded September 30, 2026, carries a $6,573,600 ceiling with completion through September 29, 2027. All delivery orders are firm fixed price with no set-aside and performance in Frederick, Maryland.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 · Incorporate vaar 852.204-72, personnel vetting and credentialing (march 2026)incorporate far 52.222-90, addressing DEI discrimination by federal contractors… $0
Supplemental Agreement for work within scope P00001 · Supplemental agreement for work within scope $0
Original award $0

Quick answers

Who was awarded contract 36C10X24D0028?

36C10X24D0028 was awarded to Fulgent Therapeutics LLC by VA Strategic Acquisition Center Frederick (Headquarters) on September 30, 2024.

How much is contract 36C10X24D0028 worth?

Orders under 36C10X24D0028 have obligated $9,529,174. Their combined current value, with exercised options, is $16,096,200. 36C10X24D0028's own ceiling is $99,032,828.

How many orders have been placed under contract 36C10X24D0028?

3 orders have been placed under 36C10X24D0028, the latest on September 30, 2026.

Who can order from contract 36C10X24D0028?

36C10X24D0028 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 36C10X24D0028 part of a contract vehicle?

Yes. 36C10X24D0028 is part of Germline PGx Services.

Was contract 36C10X24D0028 competed?

The extent of competition for 36C10X24D0028 was full and open competition. The government received 10 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV